In January, the Food and Drug Administration approved the REBOA catheter, or resuscitative endovascular balloon occlusion of the aorta. The REBOA is a device that’s inserted into a hemorrhaging vessel and stops or slows blood flow to that injury, while allowing blood flow to continue to other body